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RISK FACTORS AND RATES OF DELAYED SYMPTOMATIC 
HYPONATREMIA AFTER TRANSSPHENOIDAL SURGERY: A SYSTEMATIC 
REVIEW 
MICHAEL ACOSTA 
ABSTRACT 
Background 
Delayed symptomatic hyponatremia (DSH) is among the most common reasons for 
readmission following transsphenoidal surgery. Patients can present with a large range of 
symptoms, requiring immediate attention and prolonging hospital stay. In rare and severe 
cases, DSH can result in death. While various risk factors for DSH have been 
investigated, there is still a need for better understanding in order to identify patients who 
are at risk. Clinicians can then take preventative measures to improve patient outcomes. 
A systematic review was performed to determine both predictors and rates of DSH after 
both endoscopic (eTSS) and microscopic transsphenoidal surgery (mTSS). 
 
Methods 
We conducted a systematic search through databases MEDLINE/PUBMED, MEBASE, 
and The Cochrane Library. Included studies were selected with the following criteria: (i) 
case series with at least 10 cases reported, (ii) adult patients who underwent eTSS or 
mTSS for pituitary adenomas, and (iii) reported occurrence of DSH (hyponatremia 
defined as blood sodium level <135 mEq/L) three days post-operatively. Data were 
analyzed using CMA V.3 Statistical Software (2014). 
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Results 
We identified 10 case series that satisfied the inclusion criteria consisting of 2,947 
patients with pituitary adenomas. The following were investigated as potential predictors 
of DSH: age, CSF leak, gender, and tumor size. Rates of DSH were found to be between 
4 and 12 percent for both mTSS and eTSS.  
  
Conclusions  
Age, gender, tumor size, rate of blood sodium level decline between post-operative day 
(POD) 4 and 7, and Cushing’s disease are potential predictors of DSH. A better 
understanding of these predictors can help clinicians identify patients at risk for DSH so 
preventative measures can be taken to reduce the deleterious effects of hyponatremia 
after transsphenoidal surgery. 
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INTRODUCTION 
Diagnoses of pituitary tumors have been significantly increasing over the last two 
decades as have the number of transsphenoidal surgery resections performed per year. 
Approximately 90% of these pituitary tumors are classified as adenomas.82 Pituitary 
adenoma prevalence has been estimated to be approximately 17%.23 The pituitary gland 
comprises of different types of cells, from which these tumors will originate and can 
cause the over-secretion of hormones resulting in the term “functioning tumors”. The 
adenomas which are non-hormone-producing are “non-functioning” tumors.65 Pituitary 
adenomas mostly grow slowly over time, but can cause significantly harmful symptoms. 
Typical examples of functioning tumor disorders include Cushing’s Disease, 
prolactinoma, acromegaly, and gigantism. 
Transsphenoidal surgery is recognized as the gold standard for removing pituitary 
adenomas.79 While the majority of hyponatremic patients post-surgery are asymptomatic, 
severe and prolonged hyponatremia is associated with increased mortality.4,30 Though a 
safe and effective procedure, there are several complications that patients are at risk for. 
Hyponatremia is a known complication that often occurs in a delayed fashion. Patients 
suffering from delayed hyponatremia will typically experience symptoms between the 
fourth and seventh day post-operatively, which can be problematic as patients are often 
discharged by this time and are in their home.86 Given the severity of delayed 
symptomatic hyponatremia (DSH) and that it is among the most common causes for 
readmission within 30 days after transsphenoidal surgery,6  it is important to better 
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understand the predictors for this condition to best improve patient outcomes and quality 
of care.  
 
Historical Background of Transsphenoidal Surgery 
 The origin of transsphenoidal surgery began with the sparked interest in the 
pituitary, resulting from a paper by Pierre Marie in 1886. In this paper, the author 
describes two patients with hypertrophic pituitary glands, which was hypothesized by 
Marie to be a part of the cause of acromegaly.55 However, the hyper-secreting tumors of 
the pituitary, which were responsible for acromegaly was not known until 1910.52 It was 
only a few years after Marie’s paper when Richard Caton made the first effort to resect a 
pituitary tumor.  
In Caton’s paper in 1893, he discusses a patient in her early thirties that was in 
significant pain, deaf in both ears, already had lost vision in her right eye, and had 
impaired vision in her left eye. The patient became very weak, vomiting frequently, and 
was at the final stages of acromegaly. It became clear to Caton that her life could not be 
prolonged. He then made the decision to perform surgery in an attempt to remove the 
tumor. However, this did not turn out to be possible and he decided to create an opening 
in the skull to relieve intracranial pressure for the patient. The patient’s pain subsided 
greatly and the remaining three months of her life were relatively comfortable.12 
Over the next several years there were further attempts in transcranial approaches. 
Sir Victor Horsley, who had originally recommended the temporal approach taken by 
Caton, performed 10 operations from 1904 to 1906, which resulted in a mortality rate of 
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20%.17,52 In 1905, it was Fedor Krause who operated using a frontal transcranial approach 
which laid the groundwork for future variations of the approach by several 
neurosurgeons: Dandy, Huer, Frazier, and Cushing.52 Given the high reported mortality 
rates of transcranial approaches, other routes to the sella turcica, in which the pituitary 
gland resides, were investigated.  
David Giordano, an Italian neurosurgeon, practiced a transglabellar nasal 
technique to reach the sellar region on cadavers. The procedure consisted of a nasal-
glabellar degloving, then ethmoid bone removal, allowing an open sphenoid sinus. Parts 
of the sella turcica could then be removed.3 It was because of Giordano’s hard work that 
Hermann Schloffer was able to perform the first transsphenoidal surgery in 1907.52  
Schloffer performed the surgery in three stages. First, there was an opening made 
in the left nasolabial fold and subsequently, the nasal conchae and septum were excised. 
The next major step was removing the sphenoidal rostrum and vomer. Finally, after 
removal of the mucosa, an opening was created in the sella turcica.72,73 The patient 
Schloffer operated on, felt significant improvements in his symptoms. He did, however, 
suffer a few neurological symptoms as minor complications. Although the patient 
unfortunately died approximately two months after the surgery, Schloffer viewed the 
operation as a success for the symptomatic relief that it provided. The surgery sparked 
further interest and several surgeons improved the technique.72 
In Cushing (1909), the author treated a 38-year-old patient suffering from 
acromegaly using Schloffer’s approach for the transsphenoidal surgery. The patient, over 
the course of several years developed photophobia, headaches, enlarged tongue, feet, 
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hands, and facial features, in addition to severe pain that was so frequent it became 
constant. The stark contrast of the patient’s condition before and after the onset of 
symptoms can be seen in Figure 1. The surgery was successful and many of the patient’s 
severe symptoms lessened or subsided. In his report, Cushing noted that while he foresaw 
transsphenoidal surgery to become widely accepted, complications such as meningitis 
would serve as a barrier.19 Cushing continued to work on this operation and in 1914 
modified his method by using the sublabial approach by Albert Halstead and a 
submucosal septal resection by Theodore Kocher.16,20 For the most part, his modification 
is the same that is used by neurosurgeons today.52 
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Figure 1: Patient on whom Cushing performed transsphenoidal surgery. A) The 
patient years before the onset of symptoms. B) The patient’s condition on admission. 
(Taken and modified from Cushing et. al 1909).19 
 
Although Cushing switched back to transcranial procedures, which became 
increasingly popular in the United States, Norman Dott who studied under Cushing, kept 
the practice alive. He even developed a lighted speculum for improved visualization for 
transsphenoidal surgery.44 Gerard Guiot, learning the surgical approach from Dott, 
further improved transsphenoidal surgery by using radiofluoroscopic guidance to better 
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view the trajectory of the operation.32 It is due to both Dott and Guiot’s success that 
interest in transsphenoidal surgery became re-ignited.68  
 
The Microscope and Endoscope 
The next major development came when Hardy in 1967 introduced the operating 
microscope, which dramatically impacted transsphenoidal surgery through improved 
illumination, magnification, and visualization.44 The use of a microscope significantly 
improved the transsphenoidal operation for pituitary-related surgeries.52 Microscopic 
transsphenoidal surgery (mTSS) became a well-established, safe, and effective procedure 
for pituitary lesions.35,58,66  
The use of an endoscope was first suggested for use in transsphenoidal surgery by 
Guiot in 1963,33 but did not gain popularity in neurosurgery until later, partly due to 
optical advancements, and was only used as a complement to the microscope in certain 
cases.9 However, in these endoscopic-assisted surgeries, it was reported that the use of 
the endoscope was time-saving and reduced trauma.26,63 In 1996, Carrau et. al, wrote a 
paper detailing their experience solely using an endoscope for the technique. The authors 
praised the endoscope, predicting that endoscopic transsphenoidal surgery (eTSS) would 
soon become the preferred method for pituitary surgery.  
 
Advantages and Disadvantages of mTSS and eTSS 
There are several disadvantages to using the microscope in the transsphenoidal 
procedure, which is a major reason for the quick acceptance of the endoscope. 
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Specifically, the microscope used in the operation is restricted by both the lens and the 
light source, affecting focus and constricting view.43 Another drawback of mTSS is the 
bayonet shape of instruments, which are used in order to avoid obstruction of the light 
from the microscope.8 With mTSS, there is a reported “tunnel vision” during the 
operation and limited maneuverability of surgical instruments.53 The limited operating 
view provided by the microscope can be seen in an example in Figure 2. With the 
limitation of line of site, it is difficult for surgeons to see around corners.41 There are also 
limited angles of approach in this transsphenoidal technique due to the nasal speculum 
and transsphenoidal retractor.51,49,8 
 
Figure 2: A comparison in views using an endoscope versus a microscope. The 
comparison in views shows the larger area for visualization with the endoscope compared 
with the microscope. (Taken from Gaillard 2014)27 
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In addition to the limitations of the microscope, the success in using an 
endoscopic approach has recently lead to its increasing acceptance.44,48 The minimally 
invasive approach is also of appeal to patients.49 An advantage of the endoscope that has 
been reported is the improvement in visualization of the operating field. 25,28 Specifically, 
it has been noted by several investigators that the panoramic view provided by the 
endoscope allows for a better view of structures surrounding the carotid arteries, clivus, 
and optic nerves.1,9,67 In a paper by Cavallo et. al (2007), the authors recount their 
experience using an endoscope and offer suggestions that may ease the transition from 
microscope to endoscope. A summary of several of the advantages and disadvantages of 
eTSS as noted by these researchers is in Table 1.  
Table 1: A Summary of advantages and disadvantages in using an endoscope in 
transsphenoidal surgery. Listed advantages and disadvantages from surgeons with 
experience using a microscope and endoscope. (Taken from Cavallo et. al 2007).13 
  
 
 
Some of the listed advantages are thought to potentially help minimize disastrous 
injuries and reduce complications. The same group had previously reported that using the 
endoscope resulted in fewer complications post-operatively.10 In another study by Jho 
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and Carrau (1997), the authors report their early experience in eTSS with 50 patients and 
note visualization advantages in the suprasellar region.43 With this endoscopic approach, 
there is sometimes less pain after surgery, nasal packing is usually not necessary, and 
there are fewer nasal septal perforations.49,11,43 
However, with the use of a “pure” endoscopic approach there is a significant 
learning curve, which has been reported by many.7,11,43,49,28 In a review paper by Laws 
and Barkhoudarian, who have practiced with both microscope and endoscope, the authors 
recommended having a microscope ready, as in their early experience they found it 
appropriate to switch back to the microscopic technique when using the endoscope. 
However, with greater experience they reported converting back to the microscope less 
frequently.49 The significant limitation of operating using a two-dimensional image is a 
major reason for the current advancement in eTSS through three-dimensional endoscopy 
in the past decade.5  
 
Outcomes and Complications of Transsphenoidal Surgery 
 Given the tremendous advancements that have occurred from the first 
transsphenoidal surgery, it has been important for surgeons to report the outcomes of 
their patients. In a paper by Ciric et. al (1997), the authors investigate the overall 
complications following transsphenoidal surgery, which was conducted through a 
national survey. The authors sent out questionnaires about 14 known complications, to 
which 952 surgeons responded. In the study, the authors grouped surgeons by their 
experience from the number of transsphenoidal surgeries performed. The percent of 
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operations that resulted in a complication is shown in Table 2, which was made from 
estimates reported by the surgeons from each group. 
 
Table 2: Percent of Operations after Transsphenoidal Surgery resulting in each 
complication per experience group in the National Survey. There are further 
reductions in complications in groups with more experienced surgeons.  Taken from Ciric 
et. al 1997.15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
The authors found that greater experience resulted in fewer complications, which 
was statistically significant for all but two complications. This study was important for 
highlighting that experience performing a surgical technique can reduce complications.15 
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Considering the steep learning curve of the endoscopic technique previously mentioned, 
it is important to compare outcomes of both visualization methods of transsphenoidal 
surgery.  
 In a systematic review by Rotenburg et. al (2010), the authors investigated 
published literature from 1989 to 2009, where the  studies compared mTSS and eTSS for 
treatment of pituitary adenomas. In terms of operating time, some studies found the 
endoscopic approach to take slightly longer. However, this is likely due to the newness of 
the technique. As a whole, operating time using an endoscope was lower than that using a 
microscope. The differences in tumor resection of the included studies were considered 
insignificant.69 However, in another systematic review, there seemed to be a trend 
towards better tumor resection with eTSS when compared with mTSS.77 In Rotenburg et. 
al, the authors also found that overall, eTSS resulted in a shorter hospital stay for patients 
when compared with mTSS. The authors found that occurrence of diabetes insipidus 
(DI), immediately after the surgery was reduced in eTSS; however, long-term morbidity 
because of DI seemed to be the same between eTSS and mTSS.  
 The overall comparisons of outcomes in eTSS versus mTSS that have been 
reported are fairly mixed. In a meta-analysis conducted by Ammirati et. al (2013), the 
authors did not find any statistical significance between each visualization technique for 
the following (Table 3): CSF leak, rate of death, DI, visual complication, 
hypopituitarism, gross total resection, and nerve injury. Interestingly, they found that the 
endoscopic group experienced greater number of vascular complications.1 Overall, the 
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authors concluded that there was not a clear or significant advantage in terms of 
outcomes for eTSS over mTSS.   
 
Table 3: Estimated proportion with 95% CI of complications after eTSS and mTSS. 
(Taken and modified from Ammirati et. al 2013)1 
 
Complication No of studies 
for eTSS 
Proportion 
(95% CI) for 
eTSS 
No of 
studies 
from mTSS 
Proportion 
(95% CI) for 
mTSS 
Death 19 0.49% (0.23% to 
0.84%)† 
18 0.23% (0.10% to 
0.42%)† 
CSF leak 24 7.00% (4.84% to 
9.52%) 
19 6.34% (3.86% to 
9.37%) 
Meningitis 13 1.11% (0.64% to 
1.71%)† 
14 2.08% (0.83% to 
3.86%) 
Vascular 
complications* 
17 1.58% (1.07% to 
2.19%)† 
12 0.50% (0.28% to 
0.78%)† 
Visual loss 13 0.72% (0.37% to 
1.19%)† 
14 0.60% (0.23% to 
1.14%) 
Diabetes insipidus 
temporary 
18 9.10% (6.57% to 
11.99%) 
14 10.23% (6.50% 
to 14.69%) 
Diabetes insipidus 
permanent 
21 2.31% (1.41% to 
3.41%) 
15 4.25% (1.96% to 
7.36%) 
Hypopituitarism 17 8.51% (5.16% to 
12.59%) 
12 11.64% (5.14% 
to 20.32%) 
Complete 
resection 
22 68.77% (64.37% 
to 73.00%) 
18 64.44% (57.62% 
to 70.98%) 
Nerve injury 8 0.28% (0.05% to 
0.71%)† 
7 0.53% (0.08% to 
1.34%) 
*Vascular complication rate is higher for eTSS than mTSS (p<0.0001). 
†A fixed-effects pooled estimate was used.  
 
 However, a more recent meta-analysis by Gao et. al (2014), drew different 
conclusions. While most complications were relatively similar between groups, there 
were a few that favored eTSS. They found that gross total resection was greater in the 
endoscopic group versus the microscopic one. They also found that nasal perforations 
  13 
occurred significantly less in the endoscopic group. Patients who underwent eTSS also 
stayed at the hospital for a significantly shorter time in comparison to those who 
underwent mTSS. There were no reported differences for CSF leak, DI, meningitis, and 
epistaxis.29 In another study by DeKlotz et. al (2012), these authors also were able to 
confirm a statistically significant  improvement in gross total resection and a reduction in 
septal perforations with eTSS. The authors also found lower occurrences of CSF leaks, 
epistaxis and a shorter hospital stay for patients from the eTSS group when compared to 
mTSS. They did not find any difference between groups for DI, length of operation, or 
hospital stay.22 While the previously discussed studies have not found any significant 
difference in CSF leak events, a study by Strychowski et. al (2011) did report  a higher 
occurrence in patients treated with eTSS than those with mTSS. This study also found 
less blood loss, shorter operating times and hospital stay, and fewer nasal complications 
for eTSS patients.77 
Overall, the studies show that both mTSS and eTSS are efficacious and safe for 
treating pituitary adenomas. The inconsistency with clear conclusions regarding 
outcomes and complications may result from a few issues. One issue is that these meta-
analyses have different inclusion criteria as well as search methods, which will result in 
different, pooled analysis. Another limitation from the literature is that there are no large, 
prospective, randomized studies to best compare eTSS with mTSS. One final limitation is 
the new endoscopic technique still requires more experience due to the steeper learning 
curve. It is thought that after some time, the efficacy of the endoscopic technique will 
supersede the microscopic one.29 
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An important outcome of surgery is also the comfort or quality of life (QOL) of 
patients post-operatively. This is has not been studied closely for pituitary adenoma 
patients following transsphenoidal surgery. The first study to investigate both, quality of 
life and outcomes, for patients operated on through the endoscopic approach was done by 
Karabatsou et. al (2008). They assessed QOL through Short Form-36 health 
questionnaire. Although the impact eTSS had on QOL was statistically insignificant, 
there appeared to be a trend indicating an overall positive effect on QOL.45 This might be 
expected as it appears pain following transsphenoidal surgery is less in eTSS patients, 
which is possibly due to the lack of nasal packing and external incisions in this 
technique.25,49,69 There is also possibly greater tumor resection, leading to an improved 
endocrinological outcome.45 Future studies will need to be conducted in order to properly 
evaluate transsphenoidal technique impact on QOL.  
 
Hyponatremia 
One complication quite common with neurosurgical patients is hyponatremia. 
Hyponatremia is generally classified as having blood sodium levels below 135mEq/L. 
Mild hyponatremia is considered as sodium levels at 131-134mEq/L, moderate as 125-
130mEq/L and severe as <125mEq/L.4 Given the increased mortality associated with 
hyponatremia it is an important outcome of interest. In a study by Waiker et. al (2009), 
the authors investigated hyponatremia and mortality in over 98,000 patients. 
Hyponatremia, even mild, was found to significantly increase mortality. This effect 
became pronounced for patients with cardiovascular disease.83 The association between 
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increased mortality and hyponatremia was also found in a study of results from the 
National Health and Nutrition Examination Survey (Figure 2).57 Hyponatremia can cause 
patients to experience dizziness, nausea, and headaches.85 It has also been associated with 
demyelinating disease,59 a condition that destroys the myelin sheath surrounding nerve 
fibers, resulting in neurological problems.78 In severe cases, it can cause cardiac 
dysfunction, seizures, comas, respiratory arrest, and death.42,39 
 
 
Figure 2: Cumulative mortality in hyponatremic and normonatremic subjects. After 
adjusting for comorbidities, insurance status, smoking, and ethnicity, risk of mortality 
remained significant for subjects with hyponatremia. (Taken from Mohan et. al 2013).57 
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Causes of Hyponatremia 
The cause of hyponatremia is most commonly thought to originate from the 
syndrome of inappropriate antidiuretic hormone secretion (SIADH), and less commonly 
from cerebral salt wasting syndrome (CSWS).86 If hyponatremia occurs within the first 
three days post-operatively, cortisol deficiency or excess fluids could be considered as 
possible causes.75 Other potential causes of hyponatremia are an ACTH deficiency, 
meningitis, over-administration of DDAVP, or hypothyroidism.86,56 
Normally, the hypothalamus works in conjunction with the pituitary gland to 
produce hormones that regulate various processes inside the body, including water 
regulation. SIADH is a condition where there is an excess production of antidiuretic 
hormone by the posterior pituitary, which acts on the kidney resulting in an increased 
retention of water. This will cause the extra cellular fluid to expand with reduction of 
blood sodium concentration, which as previously discussed, can have seriously 
deleterious effects on the body.24  
In a study by Cusick et. al (1984), the authors report on three cases on patients 
who underwent pituitary tumor resection through transsphenoidal surgery. Due to normal 
thyroid functioning and proper adherence to steroid replacement therapy of these patients, 
the authors concluded the cause of hyponatremia was not hypothyroidism or 
hypoadrenalism. Hyperactivity of the posterior pituitary also did not appear to be 
responsible. The authors suggested that the cause of the hyponatremia was damage of 
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posterior pituitary cells containing antidiuretic hormone, causing low serum osmolality 
despite normal functioning of the neurohypophysis.21 In a prospective study by Olson et. 
al (1997), investigators sought to determine the pathophysiology of hyponatremia after 
transsphenoidal surgery. They evaluated posterior pituitary damage through 
questionnaires to surgeons after each operation and found that greater surgical 
manipulation and posterior pituitary damage was associated with water balance 
dysfunction.60 The association of excess antidiuretic hormone release with posterior 
pituitary damage has been reported by other studies as well.21,37,81 
The other potential cause of hyponatremia after transsphenoidal surgery is CSWS, 
which is less frequently reported.2,70,75 CSWS is a condition where excess renal excretion 
of sodium occurs, resulting in hyponatremia as well as hypovolemia.14 The first report of 
the rare condition was by Peter et. al (1950) through the description of three patients who 
were in a volume-contracted state and experiencing hyponatremia.64 However, following 
the report by Schwartz et. al on SIADH,74, CSWS was less often reported and only fairy 
recently has become known to be distinct from SIADH.62 Although the mechanism of 
this condition is not well understood, it is hypothesized that sympathetic input to the 
kidney is reduced, in addition to a release of natriuretic factors (Figure 3). While brain 
natriuretic peptide (BNP) may possibly be the main contributing factor, atrial natriuretic 
peptide (ANP) among others are thought to play a role as well.31,62  
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Figure 3: Proposed Mechanism for CSWS. Reduced renal sympathetic innervation and 
increased natriuretic factors can result in excess loss of sodium and hypovolemia as seen 
in CSWS. Abbreviations: AVP = arginine vasopressin; ANP = atrial natriuretic peptide; 
BNP = brain natriuretic peptide; EABV = effective arterial blood volume; IMCD = inner 
medullary collecting duct. (Taken from Palmer et. al 2003).62 
 
 
 While both SIADH and CSWS can result in hyponatremia, their distinction is 
important regarding treatment. SIADH is a volume-expanded state, where the 
extracellular volume is increased; CSWS is the opposite, where extracellular volume is 
decreased. The fluid restriction that serves as a treatment for SIADH would worsen the 
condition for a patient with CSWS. CSWS is usually treated through intravenous saline 
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and salt tablets, which would worsen the hyponatremia of a patient with SIADH. The 
major differentiation between the two regarding diagnosis lies with the assessment of 
extracellular fluid status.62 
 
Delayed Symptomatic Hyponatremia 
 While hyponatremia has been a known consequence of transsphenoidal surgery, 
delayed symptomatic hyponatremia (DSH) is not as often reported, but appears to be 
more common than previously thought.6 In a recent study, delayed hyponatremia was 
actually found to be the most common cause for readmission within 30 days after 
transsphenoidal surgery.6 Considering that patients will remain in the hospital post-
operatively for only a few days, DSH will often occur once a patient is at their home.86 
DSH has been reported to occur somewhere between four and seven days post-
operatively.6,36,86 
 DSH has been described and reported by several investigators.46,50,80 While 
potential risk factors for postoperative hyponatremia have been investigated, the results 
are mixed and there is no solid conclusion about which patients are at risk. One study 
found that patients with preoperative hypopituitarism were at increased risk for 
hyponatremia.40 However, this study was not focused on pituitary adenomas and also did 
not differentiate into delayed and symptomatic hyponatremia. Another study, while 
specifically investigating patients with delayed hyponatremia, only found low body mass 
index (BMI) as an increased risk factor. But like the previous study mentioned, the 
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authors included all pituitary tumors.39 While one study found that age was a predictor of 
delayed hyponatremia,50 another study reported a contradictory finding.80 
 Other potential predictors that have been investigated include: gender, tumor type, 
and tumor size, but a consensus has not been reached. Part of the difficulty in identifying 
these high-risk patients is the retrospective nature of the studies, in addition to a lack of 
clear distinction in type of hyponatremic events. It is the goal of this study to evaluate not 
only predictors, but also rates of DSH for both transsphenoidal techniques (eTSS and 
mTSS) in patients with pituitary adenomas.  
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SPECIFIC AIMS 
 The prevalence of pituitary adenomas has been increasing the last twenty years, as 
has the number of transsphenoidal surgeries that treat them.82 The two major 
developments include the use of the microscope and subsequently the endoscope, which 
both have significantly impacted tumor resection rates, operating time, recovery time, 
complications, and hospital stay. There has been much discussion over the benefits of 
each visualization method. However, the current body of evidence regarding which 
method is superior to the other is insufficient. One complication of both techniques is 
delayed symptomatic hyponatremia (DSH), which may be more common than previously 
thought. While the majority of patients who experience hyponatremia after 
transsphenoidal surgery are asymptomatic, severe and prolonged hyponatremia can cause 
significant harm to patients and is associated with increased mortality.4,30 Given the short 
hospital stays following transsphenoidal surgery, patients often experience DSH while at 
home. Predictors of delayed hyponatremia have been investigated, however, there is not 
sufficient evidence for a consensus on these risk factors. To our knowledge there is no 
meta-analysis or systematic review that has compared rates of DSH in patients with 
pituitary adenomas for mTSS and eTSS nor identified risk factors for DSH. 
The specific aims of this study are: 
1. To assess rates of DSH in patients after both mTSS and eTSS 
2. To identify predictors of DSH in patients after both mTSS and eTSS 
3. To elucidate differences in risk factors for DSH in mTSS versus eTSS 
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Through this study we hope to obtain a better understanding of risk factors and predictors 
of DSH after transsphenoidal surgery, which could allow clinicians to more accurately 
identify patients at an increased risk for this potentially catastrophic complication. For 
these high-risk patients, clinicians will be able to monitor them more closely and apply 
preventative measures to improve quality of care and patient outcomes. The goal of this 
study is to pool results from a set of case series so that we can compare DSH rates for the 
two visualization techniques as well as identify potential predictors. 
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METHODS 
 
Search strategy 
 A thorough search of the following databases was conducted: 
MEDLINE/PUBMED, EMBASE, and The Cochrane Library (Tables 4 and 5). The last 
search was performed in September 2015 and there were not limitations to our search 
strategy. 
 
Table 4: Medline search strategy using MeSH terms and text word keywords. 
(Taken from Cote et. al 2016).18 
("Neuroendoscopes"[Mesh] OR "Neuroendoscopy"[Mesh] OR Neuroendoscop*[tw] OR 
surgery endoscop*[tw] OR interventional endoscop*[tw] OR transsphenoid* [tw] OR 
transnasal endoscop*[tw] OR endoscopic endonasal[tw] OR endoscopic resection[tw] 
OR endonasal endoscop*[tw] OR endoscopic surgery [tw] OR "Neurosurgery"[Mesh] 
OR Neurosurgery [tw] OR microscop*[tw] OR "Microsurgery"[Mesh] OR 
microsurger*[tw] OR micro-surger*[tw] OR Transsphenoidal microscopic surgery [tw] 
OR microscopic transsphenoidal surgery [tw] OR microscopic endonasal 
transsphenoidal[tw]) AND ("Craniopharyngioma"[Mesh] OR pituitary adenoma [tw] OR 
pituitary gland adenoma[tw] OR "Pituitary Neoplasms"[Mesh] OR Pituitary Neoplasm* 
[tw] OR "pituitary microadenoma"[tw] OR hypophys* [tw] OR Craniopharyngioma[tw] 
OR "Hyperpituitarism"[Mesh] OR Hyperpituitarism[tw] OR "Pituitary ACTH 
Hypersecretion"[Mesh] OR "Pituitary ACTH Hypersecretion"[tw] OR 
"Prolactinoma"[tw] OR "Acromegaly"[tw] OR Cushing's Disease[tw]) AND 
("Hyponatremia"[Mesh] OR hyponatriemia[tw] OR hyponatriaemia[tw] OR 
Hyponatremia[tw] OR hyponatriaemia[tw] OR "Sodium"[Mesh] OR "Inappropriate ADH 
Syndrome"[Mesh] OR syndrome of inappropriate secretion of antidiuretic hormone[tw] 
OR SIADH[tw] OR "Natriuresis"[Mesh] OR Inappropriate ADH Syndrome [tw] OR 
inappropriate vasopressin secretion[tw] OR "Diabetes Insipidus"[Mesh] OR Diabetes 
Insipidus[tw] OR "Postoperative Complications/etiology"[Mesh]) 
Result=576 
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Table 5: Emtree keywords used in Embase search. (Taken from Cote et. al 2016).18 
exp neuroendoscopy/ OR "neuroendoscop*".tw. OR exp transsphenoidal surgery/ OR 
"transsphenoid* surger*".tw. OR "endoscop* endonasal".tw. OR "endonasal 
endoscop*".tw. OR endoscopic surgery/ OR neurosurgery/ OR microsurgery/ OR 
"microscop*".tw. OR "microsurgery*".tw. OR "micro-surger*".tw. OR "Transsphenoidal 
microscopic surgery".tw. OR "microscopic transsphenoidal surgery".tw. OR 
"microscopic endonasal transsphenoidal".tw. AND exp hypophysis tumor/ OR 
"hypophys*".tw. OR "pituitary adenoma" .tw. OR "pituitary gland adenoma".tw. OR 
"pituitary microadenoma".tw. OR craniopharyngioma/ OR hyperpituitarism/ OR 
acromegaly/ OR Cushing disease/ AND exp hyponatremia/ OR "hyponatremia".tw. OR 
"hyponatriemia".tw. OR "hyponatraemia".tw. OR "hyponatriaemia".tw. OR inappropriate 
vasopressin secretion/ OR "syndrome of inappropriate secretion of antidiuretic 
hormone".tw. OR "SIADH".tw. OR natriuresis/ OR "natriuresis".tw. OR neurogenic 
diabetes insipidus/ OR "Neurogenic Diabetes Insipidus".tw. OR "Diabetes Insipidus".tw. 
Result= 531 
 
 
Eligibility Criteria and Study Selection  
Articles that were animal studies, case reports or were not written in English 
(n=1) were excluded from the current investigation (Figure 4). The study inclusion 
criteria consisted of case series with at least 10 patients who were diagnosed with 
pituitary adenoma and were treated through microscopic or endoscopic transsphenoidal 
surgery. We were unable to identify any cohort studies or randomized control trials that 
met the study selection criteria. The primary outcome of the investigation was the 
incidence of delayed and symptomatic hyponatremia occurring on or after the third day 
post-operatively. A blood sodium level below 135 mEq/L was defined as hyponatremia. 
Each investigator evaluated the retrieved articles, using the search strategy and inclusion 
criteria, independently. Any disagreements on which studies to include were resolved by 
the senior author (TRS). 
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Figure 4: Flow chart for systematic search and selection of studies. (Taken from Cote et. 
al 2016.)18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Articles found in Pubmed (n=576) 
Articles found in Embase (n=531) 
Articles found in Cochrane Library (n=35) 
Studies included (n=867)  
Duplicates (n=275)  
Studies included (n=426) 
Case Report (n= 251) 
Meta-analysis (n= 7) 
Systematic Review (n= 5) 
Review (n= 95) 
Others (n= 83) 
Studies included (n=37) 
Articles excluded on basis 
of title and abstract 
screening (n=389) 
10 Articles included 
Not founded (n=4) 
Short Follow-up (n=2) 
Not English (n=1) 
Abstract (n=1) 
No info. About Delayed 
Hyponatremia (n=2) 
Not clear if it’s Delayed or not (n=9) 
Not clear if it’s microscopic or 
endoscopic (n=1) 
Not Systematic delayed hyponatremia 
(n=7) 
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Data Extraction 
The included articles were divided among five researchers. The data was 
extracted independently by members of the team and then reviewed by a second member. 
Any differences with data extraction were resolved by the senior author. Extracted data 
included the following: author, year of the publication, patient demographics, surgical 
technique (microscopic or endoscopic), tumor size (macroadenoma or microadenoma), 
post-operative complications, study location, whether or not the surgery was performed 
by a single surgeon, and whether or not the study included a single center. The mean age 
of each case series was used as a potential predictor. To standardize the measure for age, 
the mean for one of the investigated studies76 was estimated from the median.38  
 
Exploratory analysis 
A stratified exploratory analysis was performed using descriptive statistics, 
histograms, and scatterplots once the included studies were identified, in order to explore 
trends in the data. The exploratory analysis was useful in selecting the appropriate mode 
of meta-regression for assessing risk factors for DSH post-operatively. 
 
Risk of bias and quality assessments 
Due to the non-comparativeness of the available studies, the Newcastle-Ottawa 
Scale was modified to assess study quality with primary and secondary outcomes. The 
preferred effect measure was proportional. Egger’s test was conducted to assess possible 
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publication bias using the trim and fill technique. A sensitivity analysis was also 
conducted. 
 
Pooled analysis and heterogeneity 
Initially, the results of the investigated studies were combined statistically and 
provided a pooled estimate of the average intervention effect. The DerSimonian-Laird 
random effect model was used to assess the weighted average of the effect estimate due 
to the unknown variability of risk factors leading to DSH in the included studies. For 
comparison, fixed-effects models were evaluated. The results were shown as point 
estimates with CI and p-values. Forest plots were then created to show the individual and 
pooled effect estimate, as well as CI. Heterogeneity was visually assessed through the 
forest plots. To evaluate the heterogeneity, the Chi-square test (Cochran Q) and I2 were 
used. Heterogeneity was considered insignificant if I2 statistic was below 40%, moderate 
if between 30-60%, substantial if between 50-90%, and considerable if between 75-
100%.  Forests plots were produced to present the results of these analyses. Meta-
regression analyses and subgroup analyses were used in order to explore sources of 
heterogeneity.  
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RESULTS 
Ten case series were identified that satisfied the study selection criteria for this 
systematic review, for a total of 2,947 patients (Figure 4, Table 6). Two of the included 
studies were performed prospectively, while the remaining eight were performed 
retrospectively. The majority of patients in the investigated articles were female (60.18%) 
and had macroadenomas (58.84%). Across all studies, patients’ mean age on the date of 
the operation was 47.07 years. In five of the ten studies, surgeries were performed solely 
using the microscope, in three, only the endoscope, and the remaining two, contained a 
mixture.
  
2
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Table 3: Systematic review of DSH in patients undergoing transsphenoidal resection of pituitary lesions. (Taken and modified from Cote et. al 2016).18 
Abbreviations: No., Number; Y = Yes; N = No; N/A = Not applicable; P = Prospective; R = Retrospective 
* Median was reported. 
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Thomas 
et al. 
(2014) 
N/A 2 50 50 21 9 41 8 2 0 1 N/A N/A 4.00 USA P eTSS 
Mamelak 
et al. 
(2013) 
2006-
2011 
37 300 51.6 130 16 25 36 2 N/A 2 Y N/A 12.33 USA R eTSS 
Zada et 
al. (2007) 
1997-
2004 
11 241 48 110 183 58 33 5 5 N/A Y Y 4.56 USA R eTSS 
Kelly et 
al. (1995) 
1990-
1992 
7 99 45 32 35 64 14 5 1 1 N/A Y 7.07 USA R mTSS 
Hensen 
et al. 
(1999) 
1982-
1995 
106 1571 44.5 672 454 1078 377 N/A N/A N/A N Y 6.70 Germany R mTSS 
Sane et 
al. (1994) 
1989-
1993 
18 91 45 44 30 55 N/A N/A N/A 1 N/A Y 19.78 Finland P mTSS 
Lee JI et 
al. (2008) 
2002-
2006 
7 94 42.8 51 9 85 N/A N/A N/A N/A N/A Y 7.40 
South 
Korea 
R mTSS 
Kinoshita 
et al. 
(2011) 
2006-
2008 
9 88 47.9 28 
N/
A 
N/A 11 N/A N/A N/A N/A Y 10.23 Japan R mTSS 
Bohl et 
al. (2015) 
2011-
2014 
15 303 52.9 163 
N/
A 
N/A 4 1 N/A N/A N Y 4.95 USA R 
mTSS/
eTSS 
Sata et al. 
(2006) 
2000-
2002 
4 110 43 39 12 98 3 N/A 2 N/A N/A Y 3.64 Japan R 
mTSS/
eTSS 
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To assess publication bias for both mTSS and eTSS, the Begg and Mazumdar 
Rank Correlation Test was used. Neither was found to have any significant publication 
bias (P=0.500 for both). The level of heterogeneity was considerable and deemed too 
high for meta-analysis (I2=93.28). 
 
Rates of DSH 
The event rate of DSH from the ten investigated articles was between 3.6 to 
19.8%. Kelly et. al reported rates of 7.07%, with  serum sodium levels beginning to fall 
on around post-operative day (POD) 4, and falling to their lowest on the seventh day 
post-operatively. On average, sodium levels of patients who had symptomatic 
hyponatremia, fell to 122 mmol/L. A similar rate of DSH was reported by Hensen et. al, 
where the highest incidence occurred on POD7 (n=79). Authors from different study 
reported slightly higher rates (10.23%), with 92% of all patients experiencing lowest 
levels of blood sodium on the seventh day post-operatively.47 Mamelak et. al reported a 
similar event rate for DSH (12.33%).54 In Bohl et. al, the investigators found that DSH 
developed in 15 out of 303 patients (4.95%), while Lee et. al reported DSH occurred in 7 
of 94 patients developing DSH. In a study by Thomas et. al, the authors found that  4.0% 
of patients experienced DSH. Two other studies found similar rates of DSH 
occurrence.71,86 Sane et. al reported significantly higher incidence of DSH.  
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Predictors of DSH 
In two studies, women were more likely to experience hyponatremia than men 
were.70,86 Although not reaching statistical significance Kelly et. al found that patients 
who were older, had macroadenomas, and had evidence of pre-operative hypopituitarism 
were more  prone to experience DSH than other patients. In a study by Hensen et. al, the 
authors reported that patients with Cushing’s Disease were 2.8 times more likely to 
experience hyponatremia  when compared to patients with hormonally inactive tumors. 
These patients were also at an increased risk for DSH by a factor of 3 in comparison to 
patients with prolactinoma.36 The results from Sane et. al, also seem to suggest a 
relationship between Cushing’s Disease and DSH incidence for patients. In Kinoshita et. 
al, the rate  of blood sodium level decline was identified as an independent risk factor for 
DSH, (p=0.006), which also had a tendency to occur in patients over 60 years old 
(p=0.0346). Patients with a blood sodium decline of 10mEq/L or more between POD 4 
and 7 were at an increased risk for symptomatic hyponatremia. Tumor size, tumor type, 
and gender were not found to be predictors of DSH.47 In Lee et. al, the authors found that 
patients above the age of 50 were at a significantly higher risk in developing DSH than 
other patients (p<0.05). Bohl et. al were not able to identify any predictors of DSH.  
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DISCUSSION  
 Transsphenoidal surgery has undergone significant changes since Schoffler 
performed the first one in 1909. The use of the microscope and endoscope along with 
other advancements in transsphenoidal surgery has dramatically impacted the procedure 
and complications associated with it. While complications following transsphenoidal 
surgery have been well-documented in the literature, there are some complications such 
as DSH that are not as well understood. DSH can cause a variety of neurological 
problems and, if severe enough, even death and so it requires immediate attention. 
Generally, it has been mostly attributed to SIADH as a result of posterior pituitary 
damage, causing excess release of ADH. It less frequently reported to be caused by 
CSWS, where excess sodium is excreted in the urine.86 A deeper understanding of the 
predictors for DSH can help physicians identify patients who are at risk. They can then be 
more active in applying prevention methods/treatments, such as fluid restriction or salt 
administration, depending on the cause of hyponatremia. Although retrospective case 
series have investigated DSH, there is still no consensus on predictive risk factors. To our 
knowledge there is no meta-analysis or systematic review that has compared rates of 
DSH in patients with pituitary adenomas for mTSS and eTSS nor identified risk factors 
for DSH. 
The goal of the current study was to pool results from the included studies to 
identify possible predictors of DSH, as well as compare the rates of DSH occurrence for 
both mTSS and eTSS for patients with pituitary adenomas. Through the systematic 
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search that was conducted we were able to identify ten articles consisting of risk factors 
and rates for DSH.  
Preoperative Tumor and Patient Characteristics  
Kinoshita et. al found age (>60) was a predictor of DSH, as did another study for 
patients who were at least 50 years old.50 Kelly et. al, found a tendency for older patients 
to experience DSH, and those with evidence of preoperative hypopituitarism. Age as a 
predictive risk factor has been reported by other studies as well.34,39,84 In Kelly et. al,  
patients with macroadenomas were found to be at a statistically higher risk as well, which 
is supported by recent studies.76,84 Kinoshita et. al also found that rate of blood sodium 
level decline predicted symptoms of hyponatremia. Two of the investigated studies found 
that women had a greater tendency to experience hyponatremia,70,86 a finding that other 
studies also seem to suggest.61,71 In two other included studies, it was found that DSH 
incidence was significantly greater in patients with Cushing’s Disease in comparison to 
other patients.36,70 
 
Endoscopic versus Microscopic Transsphenoidal Surgery  
Event rates for DSH for mTSS and eTSS were found to be between 4 and 12 
percent, excluding one study that reported significantly higher rates. However, the 
authors of the paper with high rates of DSH (19.78%) note that a delayed management of 
post-operative fluid and electrolytes likely caused the high incidence among these 
patients. In addition, the reported age range was fairly large (12-76 years), which could 
have contributed to these high event rates.70 The majority of the investigated articles 
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found that blood sodium level reached a nadir around the seventh day post-operatively. 
6,36,46,47,50,70 The onset of symptoms for hyponatremia have been found to typically present 
between the fourth and seventh day after transsphenoidal surgery.34 
While pooled analysis was not possible, overall, the investigated studies seem to 
suggest a trend that rates of DSH are decreasing over time. Interestingly, there were no 
significant differences in event rates for DSH when comparing mTSS and eTSS. 
Possibly, this trend may be attributed to further developments in both surgical techniques. 
There has been a great deal of discussion over the advantages and disadvantages of both 
visualization techniques in this paper. Many surgeons have reported that there is better 
visualization with the endoscope, however, and it is thought that this can result in reduced 
damage of sinonasal structures and fewer complications.25,28,49 
 
Limitations 
A limitation of the present paper is that the heterogeneity of the included studies 
was too high for meta-analysis, weakening the conclusions made of the investigated 
papers as a whole. In addition, it was difficult making meaningful comparisons between 
mTSS and eTSS for both predictors and rates of DSH due to the lack of studies using 
only an endoscope. There were two studies that included a mixture of both microscope 
and endoscope, but failed to differentiate the two for complications. In the study by 
Kinoshita et. al, the authors reported rates of DSH that were on the higher end of the 
included studies. However, this may be due to the fact that a significant portion of the 
patients who were female (68.2%). As previously discussed, women tend to experience 
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hyponatremia more often than males as reported by two studies, and it is possible that this 
could have been a contributing factor to the higher reported event rates for DSH. In 
Hensen et. al, the authors note that the hyponatremia of several patients may have been 
caused by prolonged treatment with desmopressin, a synthetic ADH analog. 
 
Future Directions 
One of the difficulties in the selection of studies investigating predictors and rates 
of DSH is the lack of specification for the type of hyponatremia experienced by patients. 
Some studies group hyponatremic events by timing, severity, or whether the patient 
reported symptoms. Future studies might more clearly differentiate between early, 
delayed, and symptomatic hyponatremia for more accurate identification of high-risk 
patients. The large range for rates of DSH in the current paper, indicate that further 
investigation needs to be conducted to pinpoint the reasons for this observation. While it 
has been noted that there is increased visualization with the endoscope, there is also a 
steep learning curve that has been reported by many.7,11,43,49 It is possible that rates of 
DSH could be affected by this and should be taken into consideration. BMI may also be a 
variable of interest, as this has been shown to significantly increase the risk of delayed 
post-operative hyponatremia.56 Future studies should not only specifically distinguish 
hyponatremic events, but should also attempt to determine the etiology as this may be a 
significant and relevant factor in identifying high-risk patients for DSH. A large, 
prospective study may improve understanding of DSH, its etiology, and its predictors.  
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Conclusion   
To date there has not been a study that has compared rates of DSH between 
microscopic and endoscopic transsphenoidal surgery. In the current paper, the 
heterogeneity of the investigated articles was too high to pool the results for reliable 
meta-analysis, making it difficult to draw accurate conclusions. Rates of DSH in 
microscopic and endoscopic transsphenoidal surgery were found to occur between 3.6 
and 19.8% in patients. In the present paper, age, gender, tumor size, rate of blood sodium 
level decline, and patients with Cushing’s Disease, were identified as potential risk 
factors for DSH following transsphenoidal pituitary surgery in patients diagnosed with 
pituitary adenoma. 
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